Analysts expect Trupanion Inc (NASDAQ:TRUP) to post ($0.01) earnings per share for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Trupanion’s earnings, with the highest EPS estimate coming in at $0.00 and the lowest estimate coming in at ($0.03). Trupanion posted earnings of $0.01 per share during the same quarter last year, which suggests a negative year over year growth rate of 200%. The business is scheduled to issue its next quarterly earnings results on Thursday, November 1st.
On average, analysts expect that Trupanion will report full year earnings of ($0.08) per share for the current year, with EPS estimates ranging from ($0.11) to ($0.05). For the next fiscal year, analysts expect that the business will post earnings of $0.12 per share, with EPS estimates ranging from ($0.05) to $0.26. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover Trupanion.
Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 2nd. The financial services provider reported ($0.01) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.05) by $0.04. The firm had revenue of $73.39 million during the quarter, compared to analyst estimates of $72.70 million. Trupanion had a negative net margin of 0.84% and a negative return on equity of 4.43%. The business’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.02) EPS.
Several equities research analysts recently issued reports on TRUP shares. Craig Hallum started coverage on shares of Trupanion in a report on Thursday, July 19th. They issued a “buy” rating and a $55.00 target price for the company. Raymond James started coverage on shares of Trupanion in a report on Thursday, September 6th. They issued an “outperform” rating and a $46.00 target price for the company. BidaskClub lowered shares of Trupanion from a “buy” rating to a “hold” rating in a report on Tuesday, August 14th. Stifel Nicolaus increased their target price on shares of Trupanion from $40.00 to $43.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. Finally, Canaccord Genuity increased their target price on shares of Trupanion from $40.00 to $46.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Trupanion presently has an average rating of “Buy” and a consensus target price of $45.22.
In other Trupanion news, Director Murray B. Low sold 3,000 shares of the stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $38.12, for a total transaction of $114,360.00. Following the completion of the sale, the director now directly owns 189,782 shares of the company’s stock, valued at approximately $7,234,489.84. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Tuesday, September 11th. The shares were sold at an average price of $34.74, for a total transaction of $138,960.00. Following the sale, the insider now directly owns 1,285,989 shares of the company’s stock, valued at $44,675,257.86. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 23,450 shares of company stock valued at $908,039. Insiders own 20.70% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the business. SG Americas Securities LLC purchased a new stake in Trupanion during the 2nd quarter valued at approximately $100,000. First Mercantile Trust Co. purchased a new stake in Trupanion during the 2nd quarter valued at approximately $142,000. US Bancorp DE grew its holdings in Trupanion by 111.8% during the 2nd quarter. US Bancorp DE now owns 4,512 shares of the financial services provider’s stock valued at $175,000 after buying an additional 2,382 shares in the last quarter. Xact Kapitalforvaltning AB purchased a new stake in Trupanion during the 2nd quarter valued at approximately $224,000. Finally, S&CO Inc. purchased a new stake in Trupanion during the 2nd quarter valued at approximately $232,000. 94.00% of the stock is owned by institutional investors and hedge funds.
Trupanion stock opened at $33.96 on Tuesday. The company has a market capitalization of $1.13 billion, a P/E ratio of -485.14 and a beta of 0.58. Trupanion has a 12-month low of $23.08 and a 12-month high of $46.70. The company has a quick ratio of 3.04, a current ratio of 3.04 and a debt-to-equity ratio of 0.16.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Read More: Outstanding Shares, Buying and Selling Stocks
Get a free copy of the Zacks research report on Trupanion (TRUP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.